Comprehensive Development Support Pace Life Sciences offers end-to-end services spanning early-phase R&D to commercial GMP manufacturing, providing a valuable opportunity to partner with pharmaceutical companies seeking integrated development support throughout their product lifecycle.

Digital Transformation Leadership Recent collaboration with Cenevo for digital lab transformation highlights Pace's commitment to innovative, technology-driven solutions, making them an attractive partner for clients investing in digital modernization of their labs and processes.

Growth Potential With annual revenues estimated between $25 million and $50 million and a small team, Pace presents significant room for expansion by targeting similar biotech and pharma clients looking for flexible, personalized CDMO and CRO services.

Leadership Strength Appointment of Dawn Von Rohr as Division President signals strategic focus on leadership and growth, providing potential entry points for sales teams to engage with decision-makers driving company expansion.

Industry Positioning Positioned within a competitive landscape with companies like Quotient Sciences and Lonza, Pace's niche focus on supportive services and digital innovation can be leveraged to differentiate their offerings, fostering targeted business development efforts.